niraparib
janssen,zai lab,gsk
['prime', 'ovarian', 'zailab']
today at #asco22, we will be presenting data from a new subgroup analysis of the phase 3 prime study in patients with advanced #ovariancancer. learn more: 
Zai Lab is an innovative biopharmaceutical company based in China and the U.S. focused on bringing transformative medicine to patients around the world.